DOCSLIB.ORG

The Role of IL-15 in Activating STAT5 and Fine-Tuning IL-17A Production in CD4 T Lymphocytes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of IL-15 in Activating STAT5 and Fine-Tuning IL-17A Production in CD4 T Lymphocytes The Role of IL-15 in Activating STAT5 and Fine-Tuning IL-17A Production in CD4 T Lymphocytes This information is current as Pushpa Pandiyan, Xiang-Ping Yang, Senthil S. of September 25, 2021. Saravanamuthu, Lixin Zheng, Satoru Ishihara, John J. O'Shea and Michael J. Lenardo J Immunol 2012; 189:4237-4246; Prepublished online 19 September 2012; doi: 10.4049/jimmunol.1201476 Downloaded from http://www.jimmunol.org/content/189/9/4237 Supplementary http://www.jimmunol.org/content/suppl/2012/09/19/jimmunol.120147 Material 6.DC1 http://www.jimmunol.org/ References This article cites 56 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/189/9/4237.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 25, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Role of IL-15 in Activating STAT5 and Fine-Tuning IL-17A Production in CD4 T Lymphocytes Pushpa Pandiyan,*,† Xiang-Ping Yang,‡ Senthil S. Saravanamuthu,x Lixin Zheng,* Satoru Ishihara,{ John J. O’Shea,‡ and Michael J. Lenardo* IL-15 is an important IL-2–related cytokine whose role in Th17 cell biology has not been fully elucidated. In this study, we show that exogenous IL-15 decreased IL-17A production in Th17 cultures. Neutralization of IL-15 using an Ab led to increases in IL- 17A production in Th17 cultures. Both Il152/2 and Il15r2/2 T cell cultures displayed higher frequency of IL-17A producers and higher amounts of IL-17A in the supernatants compared with those of wild-type (WT) cells in vitro. IL-15 down-modulated IL- 17A production independently of retinoic acid-related orphan receptor-gt, Foxp3, and IFN-g expression. Both Th17 cells and APCs produced IL-15, which induced binding of STAT5, an apparent repressor to the Il17 locus in CD4 T cells. Also, in a model of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE), Il152/2 mice displayed exac- Downloaded from erbated inflammation—correlating with increased IL-17A production by their CD4+ T cells—compared with WT controls. Exogenous IL-15 administration and IL-17A neutralization reduced the severity of EAE in Il152/2 mice. Taken together, these data indicate that IL-15 has a negative regulatory role in fine-tuning of IL-17A production and Th17-mediated inflammation. The Journal of Immunology, 2012, 189: 4237–4246. helper 17 cells are a subset of CD4+ T lymphocytes that cytokines such as IL-6, IL-21, and IL-23 promote Th17 dif- http://www.jimmunol.org/ are implicated in host defense against extracellular bac- ferentiation (7, 8). In contrast, STAT5, IL-2, and IL-27 negatively T teria and fungi (1–4). Although Th17 responses are im- regulate Th17 responses (9–12). However, the function of IL-15, a portant for host defense, they also contribute to immunopathology key cytokine for the development and proliferation of CD8 T cells in various disease settings. Th17 responses have been documented in and NK T cells, in regulation of Th17 responses has not been fully chronic inflammation and autoimmune diseases such as inflamma- elucidated. tory bowel disease (IBD), multiple sclerosis (MS), and rheumatoid IL-15 is one of the common g-chain (gc) cytokines similar and arthritis (RA) (5, 6). Because both protective and harmful effects structurally homologous to IL-2 and has pleiotropic roles in im- of Th17 cells during infection and chronic inflammation have been mune system development and lymphocyte homeostasis (13, 14). by guest on September 25, 2021 described, it is critical to study how Th17 responses are regulated The IL-15R consists of IL-15Ra (CD215), IL-2Rb (CD122), and in vivo. At the molecular level, transcription factors such as reti- the common g (CD132) chains. In addition to sharing the b and gc noic acid-related orphan receptor (ROR)-a and -gt and STAT3 and receptor subunits, IL-2 and IL-15 also share biological actions; namely, antiapoptotic effects on T cells, stimulation of NK cell *Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, proliferation, and cytolytic activity (15–18). However, striking † National Institutes of Health, Bethesda, MD 20892; Department of Biological Sci- differences are observed between the phenotypes of IL-2 and IL- ences, School of Dental Medicine, Case Western Reserve University, Cleveland, OH 2/2 44106; ‡Molecular Immunology and Inflammation Branch, National Institute of Ar- 15 knockout ( ) mice (17). This may be partly due to differ- thritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, ences in the expression patterns of these two cytokines (19). MD 20892; xLaboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892; and {Laboratory of Whereas IL-2 is expressed primarily by activated CD4 T cells, IL- Cellular and Molecular Immunology, National Institute of Allergy and Infectious 15 is expressed mainly in nonlymphoid cells including the pa- Diseases, National Institutes of Health, Bethesda, MD 20892 renchymal cells of many organs, keratinocytes, skeletal muscle Received for publication May 31, 2012. Accepted for publication August 20, 2012. cells, and APCs such as monocytes and dendritic cells (20–24). In This work was supported by the intramural research program of the National Institute the nervous system, IL-15 is expressed by neurons, astrocytes, and of Allergy and Infectious Diseases, National Institutes of Health. P.P. was partially microglia (25, 26). Although initially it was believed that IL-15 is supported by a fellowship from the National Research Council, National Academy of Sciences. expressed in lymphocytes, recent studies have suggested that P.P. designed the study, performed experiments, and analyzed data with the supervi- activated lymphocytes indeed express IL-15 (21–24). The major sion of M.J.L. P.P. wrote and M.J.L. edited the manuscript. L.Z. measured the weight cells responding to IL-15 are lymphocytes, especially NK and of the mice, helped with manuscript preparation, recorded experimental autoimmune encephalomyelitis scores in masked fashion, and contributed to discussions. S.I. and memory T cells. Macrophage- and dendritic cell-derived IL-15Ra S.S.S. performed real-time PCR experiments and analyzed the data. J.J.O. and X.-P. binds to N-glycosylated IL-15 within the endoplasmic reticulum Y. helped P.P. in chromatin immunoprecipitation experiments. and brings IL-15 to the cell surface to deliver membrane-bound Address correspondence and reprint requests to Dr. Michael J. Lenardo and Dr. agonistic signals. This cell contact-dependent mechanism, called Pushpa Pandiyan, National Institutes of Health, 10 Center Drive, Building 10, Room 11N246, Bethesda, MD 20892. E-mail addresses: [email protected] (M.J.L.) and trans-presentation, is an important step in transmitting physio- [email protected] (P.P.) logical IL-15Ra–IL-15 signals to most cells (27). After receptor The online version of this article contains supplemental material. engagement, IL-15 signaling activates both STAT3 and STAT5 Abbreviations used in this article: gc, g-chain; ChIP, chromatin immunoprecipitation; transcription factors to exert its regulatory functions in immune EAE, experimental autoimmune encephalomyelitis; IBD, inflammatory bowel dis- cells (28). ease; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; qPCR, quantitative PCR; qRT-PCR, quantitative real-time PCR; RA, rheumatoid arthritis; IL-15 has been implicated in a variety of inflammatory con- ROR, retinoic acid-related orphan receptor; WT, wild-type. ditions. Increased circulating IL-15 levels have been found in www.jimmunol.org/cgi/doi/10.4049/jimmunol.1201476 4238 IL-15 RESTRICTS Th17 RESPONSES Crohn’s and ulcerative colitis patients, implying that IL-15 pro- anti-CD3 and 3 mg/ml anti-CD28 Abs under Th0 or Th17 conditions for 3– motes the disease (29, 30). However, one study has shown that IL- 8 d. Th0 cells were stimulated only with anti-CD3 and anti-CD28 Abs with 15 protects against colitis in mice (31). Whether IL-15 controls no added cytokines, and Th17 cells were polarized using IL-6 (20 ng/ml), TGF-b (2 ng/ml), anti–IFN-g (6 mg/ml) and anti–IL-4 (6 mg/ml). Where IBD directly by regulating Th17 cells is unknown. In patients with indicated, APCs were added at a T cell/APC ratio of 1:1, and T cells were RA, IL-15 is considered proinflammatory, and blocking of IL-15 CFSE labeled to assess their proliferation. When indicated, cytokines, using anti–IL-15 mAb (HuMax-IL-15) ameliorated symptoms anti–IL-15 (20 mg/ml), and anti–IL-2 (10 mg/ml) were added at the be- (32). In the mouse collagen-induced arthritis model, although ginning of stimulation of cocultures. 2/2 wild-type (WT) and Il15 mice showed equal susceptibility to Quantitative PCR analyses the disease, transgenic overexpression of IL-15 increased the disease severity by enhancing the proliferation of CD4 T cells and For quantitative PCR (qPCR) analyses of ROR-a, ROR-gt, Foxp3, and IL- their production of IFN-g and IL-17A (33). Again, whether or not 17A mRNA, naive CD4 T cells were stimulated in Th17 cultures as de- scribed earlier, and RNA was recovered using an RNeasy Micro Kit IL-15 exerts a direct effect on IL-17A expression in CD4 cells and (Qiagen).
Load more

Recommended publications
  • Type I Interferons and the Development of Impaired Vascular Function and Repair in Human and Murine Lupus
    Type I Interferons and the Development of Impaired Vascular Function and Repair in Human and Murine Lupus by Seth G Thacker A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Immunology) in The University of Michigan 2011 Doctoral Committee: Associate Professor Mariana J. Kaplan, Chair Professor David A. Fox Professor Alisa E. Koch Professor Matthias Kretzler Professor Nicholas W. Lukacs Associate Professor Daniel T. Eitzman © Seth G Thacker 2011 Sharon, this work is dedicated to you. This achievement is as much yours as it is mine. Your support through all six years of this Ph.D. process has been incredible. You put up with my countless miscalculations on when I would finish experiments, and still managed to make me and our kids feel loved and special. Without you this would have no meaning. Sharon, you are the safe harbor in my life. ii Acknowledgments I have been exceptionally fortunate in my time here at the University of Michigan. I have been able to interact with so many supportive people over the years. I would like to express my thanks and admiration for my mentor. Mariana has taught me so much about writing, experimental design and being a successful scientist in general. I could never have made it here without her help. I would also like to thank Mike Denny. He had a hand in the beginning of all of my projects in one way or another, and was always quick and eager to help in whatever way he could. He really made my first year in the lab successful.
    [Show full text]
  • The Combination of IL-12 and IL-18 NK/T-NK Cells Derived with IL-2, IL-15
    Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-18 This information is current as Bernard R. Lauwerys, Nathalie Garot, Jean-Christophe of September 28, 2021. Renauld and Frédéric A. Houssiau J Immunol 2000; 165:1847-1853; ; doi: 10.4049/jimmunol.165.4.1847 http://www.jimmunol.org/content/165/4/1847 Downloaded from References This article cites 31 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/165/4/1847.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-181 Bernard R. Lauwerys,* Nathalie Garot,* Jean-Christophe Renauld,†‡ and Fre´de´ric A.
    [Show full text]
  • Interleukin-18 in Health and Disease
    International Journal of Molecular Sciences Review Interleukin-18 in Health and Disease Koubun Yasuda 1 , Kenji Nakanishi 1,* and Hiroko Tsutsui 2 1 Department of Immunology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; [email protected] 2 Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-798-45-6573 Received: 21 December 2018; Accepted: 29 January 2019; Published: 2 February 2019 Abstract: Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. Therefore, IL-12 is a commitment factor that induces the development of Th1 cells. In contrast, IL-18 is a proinflammatory cytokine that facilitates type 1 responses. However, IL-18 without IL-12 but with IL-2, stimulates NK cells, CD4+ NKT cells, and established Th1 cells, to produce IL-3, IL-9, and IL-13. Furthermore, together with IL-3, IL-18 stimulates mast cells and basophils to produce IL-4, IL-13, and chemical mediators such as histamine. Therefore, IL-18 is a cytokine that stimulates various cell types and has pleiotropic functions. IL-18 is a member of the IL-1 family of cytokines. IL-18 demonstrates a unique function by binding to a specific receptor expressed on various types of cells.
    [Show full text]
  • IL-1Β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 From
    Published June 24, 2019, doi:10.4049/jimmunol.1900318 The Journal of Immunology IL-1b Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells David I. Weiss,*,† Feiyang Ma,†,‡ Alexander A. Merleev,x Emanual Maverakis,x Michel Gilliet,{ Samuel J. Balin,* Bryan D. Bryson,‖ Maria Teresa Ochoa,# Matteo Pellegrini,*,‡ Barry R. Bloom,** and Robert L. Modlin*,†† Th17 cells play a critical role in the adaptive immune response against extracellular bacteria, and the possible mechanisms by which they can protect against infection are of particular interest. In this study, we describe, to our knowledge, a novel IL-1b dependent pathway for secretion of the antimicrobial peptide IL-26 from human Th17 cells that is independent of and more rapid than classical TCR activation. We find that IL-26 is secreted 3 hours after treating PBMCs with Mycobacterium leprae as compared with 48 hours for IFN-g and IL-17A. IL-1b was required for microbial ligand induction of IL-26 and was sufficient to stimulate IL-26 release from Th17 cells. Only IL-1RI+ Th17 cells responded to IL-1b, inducing an NF-kB–regulated transcriptome. Finally, supernatants from IL-1b–treated memory T cells killed Escherichia coli in an IL-26–dependent manner. These results identify a mechanism by which human IL-1RI+ “antimicrobial Th17 cells” can be rapidly activated by IL-1b as part of the innate immune response to produce IL-26 to kill extracellular bacteria. The Journal of Immunology, 2019, 203: 000–000. cells are crucial for effective host defense against a wide and neutrophils.
    [Show full text]
  • Proinflammatory T Helper Type 17 Cells Are Effective B-Cell Helpers
    Proinflammatory T helper type 17 cells are effective B-cell helpers Meike Mitsdoerffera, Youjin Leea, Anneli Jägera, Hye-Jung Kimb, Thomas Kornc, Jay K. Kollsd, Harvey Cantorb,1, Estelle Bettellie,1, and Vijay K. Kuchrooa,1 aCenter for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; bDana-Farber Cancer Institute, Boston, MA 02115; cDepartment of Neurology, Technical University Munich, 81675 Munich, Germany; dLouisiana State University Health Sciences Center, New Orleans, LA 70112; and eBenaroya Research Institute, Seattle, WA 98101 Contributed by Harvey Cantor, July 1, 2010 (sent for review May 11, 2010) T helper type 17 (TH17) cells are highly proinflammatory effector collaboration. TH1 and TH2 cells are known to provide B-cell T cells that are characterized by the production of high amounts of help, and their signature cytokines IFN-γ and IL-4 induce class IL-17A, IL-17F, IL-21, and IL-22. Furthermore, TH17 cells have been switch recombination to IgG2a or IgG1 and IgE, respectively (9, associated with a number of autoimmune diseases. However, it is 10). Using IFN-γ and IL-4 reporter mice, Reinhardt et al. (11) not clear whether TH17 cells can also serve as effective helper cells. demonstrated that B cells form conjugates with antigen-activated, Here we show that TH17 cells can function as B-cell helpers in cytokine-producing effector T cells and that the profile of cyto- that they not only induce a strong proliferative response of B cells kine production defines isotype class switching in conjugated B in vitro but also trigger antibody production with class switch cells.
    [Show full text]
  • IL-17-Producing Cells in Tumor Immunity: Friends Or Foes?
    Immune Netw. 2020 Feb;20(1):e6 https://doi.org/10.4110/in.2020.20.e6 pISSN 1598-2629·eISSN 2092-6685 Review Article IL-17-Producing Cells in Tumor Immunity: Friends or Foes? Da-Sol Kuen 1,2, Byung-Seok Kim 1, Yeonseok Chung 1,2,* 1Laboratory of Immune Regulation, Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea 2BK21 Plus Program, Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea Received: Dec 29, 2019 Revised: Jan 25, 2020 ABSTRACT Accepted: Jan 26, 2020 IL-17 is produced by RAR-related orphan receptor gamma t (RORγt)-expressing cells *Correspondence to including Th17 cells, subsets of γδT cells and innate lymphoid cells (ILCs). The biological Yeonseok Chung significance of IL-17-producing cells is well-studied in contexts of inflammation, Laboratory of Immune Regulation and BK21 Plus Program, Institute of Pharmaceutical autoimmunity and host defense against infection. While most of available studies in tumor + Sciences, Seoul National University, 1 Gwanak- immunity mainly focused on the role of T-bet-expressing cells, including cytotoxic CD8 ro, Gwanak-gu, Seoul 08826, Korea. T cells and NK cells, and their exhaustion status, the role of IL-17-producing cells remains E-mail: [email protected] poorly understood. While IL-17-producing T-cells were shown to be anti-tumorigenic in Copyright © 2020. The Korean Association of adoptive T-cell therapy settings, mice deficient in type 17 genes suggest a protumorigenic Immunologists potential of IL-17-producing cells. This review discusses the features of IL-17-producing This is an Open Access article distributed cells, of both lymphocytic and myeloid origins, as well as their suggested pro- and/or anti- under the terms of the Creative Commons tumorigenic functions in an organ-dependent context.
    [Show full text]
  • BAFF Suppresses IL-15 Expression in B Cells
    BAFF Suppresses IL-15 Expression in B Cells Ning Ma, Chen Xing, He Xiao, Youdi He, Gencheng Han, Guojiang Chen, Chunmei Hou, Bernadette Marrero, Yujuan Wang, Shengquan Zhang, Beifen Shen, Yan Li and Renxi This information is current as Wang of September 28, 2021. J Immunol 2014; 192:4192-4201; Prepublished online 26 March 2014; doi: 10.4049/jimmunol.1302132 http://www.jimmunol.org/content/192/9/4192 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2014/03/26/jimmunol.130213 Material 2.DCSupplemental http://www.jimmunol.org/ References This article cites 39 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/192/9/4192.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 28, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology BAFF Suppresses IL-15 Expression in B Cells Ning Ma,*,†,1 Chen Xing,*,1 He Xiao,*,1 Youdi He,‡ Gencheng Han,* Guojiang Chen,* Chunmei Hou,* Bernadette Marrero,x Yujuan Wang,{ Shengquan Zhang,‖ Beifen Shen,* Yan Li,* and Renxi Wang* Clinical trials have shown that BAFF inhibitors do not reduce memory B cell levels but can reduce the number of mature B cells.
    [Show full text]
  • Evolutionary Divergence and Functions of the Human Interleukin (IL) Gene Family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W
    UPDATE ON GENE COMPLETIONS AND ANNOTATIONS Evolutionary divergence and functions of the human interleukin (IL) gene family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W. Nebert3* and Vasilis Vasiliou1 1Molecular Toxicology and Environmental Health Sciences Program, Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO 80045, USA 2Department of Clinical Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA 3Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267–0056, USA *Correspondence to: Tel: þ1 513 821 4664; Fax: þ1 513 558 0925; E-mail: [email protected]; [email protected] Date received (in revised form): 22nd September 2010 Abstract Cytokines play a very important role in nearly all aspects of inflammation and immunity. The term ‘interleukin’ (IL) has been used to describe a group of cytokines with complex immunomodulatory functions — including cell proliferation, maturation, migration and adhesion. These cytokines also play an important role in immune cell differentiation and activation. Determining the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response. ILs can also have pro- and anti-inflammatory effects, further complicating their characterisation. These molecules are under constant pressure to evolve due to continual competition between the host’s immune system and infecting organisms; as such, ILs have undergone significant evolution. This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organisation. Within the literature there are a number of overlapping nomenclature and classification systems derived from biological function, receptor-binding properties and originating cell type.
    [Show full text]
  • Discovery of a Novel IL-15 Based Protein with Improved
    www.nature.com/scientificreports OPEN Discovery of a novel IL-15 based protein with improved developability and efcacy for Received: 1 November 2017 Accepted: 30 April 2018 cancer immunotherapy Published: xx xx xxxx Qiyue Hu, Xin Ye, Xiangdong Qu, Dongbing Cui, Lei Zhang, Zhibin Xu, Hong Wan, Lianshan Zhang & Weikang Tao Interleukin-15 (IL-15) can promote both innate and adaptive immune reactions by stimulating CD8+/ CD4+ T cells and natural killer cells (NK) while showing no efect in activating T-regulatory (Treg) cells or inducing activation-associated death among efector T cells and NK cells. Thus, IL-15 is considered as one of the most promising molecules for antitumor immune therapy. To improve the drug-like properties of natural IL-15, we create an IL-15-based molecule, named P22339, with the following characteristics: 1) building a complex of IL-15 and the Sushi domain of IL-15 receptor α chain to enhance the agonist activity of IL-15 via transpresentation; 2) through a rational structure-based design, creating a disulfde bond linking the IL-15/Sushi domain complex with an IgG1 Fc to augment its half-life. P22339 demonstrates excellent developability, pharmacokinetic and pharmacodynamic properties as well as antitumor efcacy in both in vitro assessments and in vivo studies. It signifcantly suppresses tumor growth and metastasis in rodent models, and activates T efector cells and NK cells in cynomolgus monkey. Overall, these data suggest that P22339 has a great potential for cancer immunotherapy. Interleukin 15 (IL-15) is a cytokine of about 12–14 KD discovered by Grabstein et al.
    [Show full text]
  • Human Cytokine Response Profiles
    Comprehensive Understanding of the Human Cytokine Response Profiles A. Background The current project aims to collect datasets profiling gene expression patterns of human cytokine treatment response from the NCBI GEO and EBI ArrayExpress databases. The Framework for Data Curation already hosted a list of candidate datasets. You will read the study design and sample annotations to select the relevant datasets and label the sample conditions to enable automatic analysis. If you want to build a new data collection project for your topic of interest instead of working on our existing cytokine project, please read section D. We will explain the cytokine project’s configurations to give you an example on creating your curation task. A.1. Cytokine Cytokines are a broad category of small proteins mediating cell signaling. Many cell types can release cytokines and receive cytokines from other producers through receptors on the cell surface. Despite some overlap in the literature terminology, we exclude chemokines, hormones, or growth factors, which are also essential cell signaling molecules. Meanwhile, we count two cytokines in the same family as the same if they share the same receptors. In this project, we will focus on the following families and use the member symbols as standard names (Table 1). Family Members (use these symbols as standard cytokine names) Colony-stimulating factor GCSF, GMCSF, MCSF Interferon IFNA, IFNB, IFNG Interleukin IL1, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL9, IL10, IL11, IL12, IL13, IL15, IL16, IL17, IL18, IL19, IL20, IL21, IL22, IL23, IL24, IL25, IL26, IL27, IL28, IL29, IL30, IL31, IL32, IL33, IL34, IL35, IL36, IL36RA, IL37, TSLP, LIF, OSM Tumor necrosis factor TNFA, LTA, LTB, CD40L, FASL, CD27L, CD30L, 41BBL, TRAIL, OPGL, APRIL, LIGHT, TWEAK, BAFF Unassigned TGFB, MIF Table 1.
    [Show full text]
  • Usefulness of IL-21, IL-7, and IL-15 Conditioned Media for Expansion of Antigen-Specific CD8+ T Cells from Healthy Donor-Pbmcs Suitable for Immunotherapy
    Cellular Immunology 360 (2021) 104257 Contents lists available at ScienceDirect Cellular Immunology journal homepage: www.elsevier.com/locate/ycimm Research paper Usefulness of IL-21, IL-7, and IL-15 conditioned media for expansion of antigen-specific CD8+ T cells from healthy donor-PBMCs suitable for immunotherapy Julian´ A. Chamucero-Millares a,b, David A. Bernal-Est´evez b, Carlos A. Parra-Lopez´ a,* a Immunology and Translational Medicine Research Group, Department of Microbiology, School of Medicine, Universidad Nacional de Colombia, Carrera 30 No. 45-03, Bogota,´ South-America, Colombia b Immunology and Clinical Oncology Research Group, Fundacion´ Salud de los Andes, Calle 44 #58-05, Bogota,´ South-America, Colombia ARTICLE INFO ABSTRACT Keywords: Clonal anergy and depletion of antigen-specific CD8+ T cells are characteristics of immunosuppressed patients Antigen-specific T cells such as cancer and post-transplant patients. This has promoted translational research on the adoptive transfer of Monocyte-derived dendritic cells T cells to restore the antigen-specific cellular immunity in these patients. In the present work, we compared the Dendritic cell-based immunotherapy capability of PBMCs and two types of mature monocyte-derived DCs (moDCs) to prime and to expand ex-vivo Adoptive cell transfer antigen-specific CD8+ T cells using culture conditioned media supplemented with IL-7, IL-15, and IL-21. The Cancer immunotherapy Viral immunity data obtained suggest that protocols involving moDCs are as efficient as PBMCs-based cultures in expanding CD8 T cell antigen-specific CD8+ T cell to ELA and CMV model epitopes. These three gamma common chain cytokines Immunological memory promote the expansion of naïve-like and central memory CD8+ T cells in PBMCs-based cultures and the expansion of effector memory T cells when moDCs were used.
    [Show full text]
  • IL-15 Triggers an Antiapoptotic Pathway in Human Intraepithelial Lymphocytes That Is a Potential New Target in Celiac Disease
    IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease– associated inflammation and lymphomagenesis Georgia Malamut, … , Nadine Cerf-Bensussan, Bertrand Meresse J Clin Invest. 2010;120(6):2131-2143. https://doi.org/10.1172/JCI41344. Research Article Gastroenterology Enteropathy-associated T cell lymphoma is a severe complication of celiac disease (CD). One mechanism suggested to underlie its development is chronic exposure of intraepithelial lymphocytes (IELs) to potent antiapoptotic signals initiated by IL-15, a cytokine overexpressed in the enterocytes of individuals with CD. However, the signaling pathway by which IL- 15 transmits these antiapoptotic signals has not been firmly established. Here we show that the survival signals delivered by IL-15 to freshly isolated human IELs and to human IEL cell lines derived from CD patients with type II refractory CD (RCDII) — a clinicopathological entity considered an intermediary step between CD and enteropathy-associated T cell lymphoma — depend on the antiapoptotic factors Bcl-2 and/or Bcl-xL. The signals also required IL-15Rβ, Jak3, and STAT5, but were independent of PI3K, ERK, and STAT3. Consistent with these data, IELs from patients with active CD and RCDII contained increased amounts of Bcl-xL, phospho-Jak3, and phospho-STAT5. Furthermore, incubation of patient duodenal biopsies with a fully humanized human IL-15–specific Ab effectively blocked Jak3 and STAT5 phosphorylation. In addition, treatment with this Ab induced IEL apoptosis and wiped out the massive IEL accumulation in mice overexpressing human IL-15 in their gut epithelium. Together, our results delineate the IL-15–driven survival pathway in human IELs and demonstrate that IL-15 and its downstream effectors are meaningful therapeutic targets in RCDII.
    [Show full text]